Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adult acellular pertussis booster memory response study
NL-OMON50704Phase 4Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Apr 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acellular pertussis vaccine in pertussis, sponsored by National Institute for Public Health and the Environment. Primary endpoints: Pertussis-specific serum IgG kinetics and Memory B-cell and T-cell responses to Bordetella pertussis proteins. Started Apr 2014; status: active, not recruiting.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on NL-OMON50704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50704.